Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Drugs. 2023 Sep 20. doi: 10.1007/s40265-023-01938-w. Online ahead of print.ABSTRACTNovel agents addressing non-amyloid, non-tau targets in Alzheimer's Disease (AD) comprise 70% of the AD drug...